Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Beyond Meat Inc (BYND) vs Cognizant Technology Solutions Corp (CTSH) Price & Performance

Beyond Meat IncTrade
Cognizant Technology Solutions CorpTrade

Price performance (Past 24H)

Key statistics

Beyond Meat Inc vs Cognizant Technology Solutions Corp — how do they compare? Beyond Meat Inc trades at $0.64 (market cap $320.23M), while Cognizant Technology Solutions Corp trades at $43.7 (market cap $20.34B). The key difference: Cognizant Technology Solutions Corp is far larger — about 63.5× Beyond Meat Inc's market cap, and Cognizant Technology Solutions Corp pays a 3.07% dividend while Beyond Meat Inc pays none. Which is the better fit depends on your goals.

BYNDCTSH
Market Cap
$320.23M$20.34B
Sector
Consumer StaplesTechnology
52-Week High
$4.28$86.70
52-Week Low
$0.52$38.73
Enterprise Value
$630.23M$19.92B
Dividend Yield
3.07%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Beyond Meat Inc

BYND trades at $0.63, down 4.15% today, reflecting persistent bearish sentiment amid declining revenues and negative cash flow from operations. The stock shows technical weakness with moving averages signaling bearish momentum, though oversold RSI conditions suggest potential for near-term bounce. Recent earnings show mixed results with Q1 2026 beating expectations but Q4 2025 and Q3 2025 missing estimates. The company continues expansion efforts with new product launches including Beyond Steak Filet and protein beverages.

Investment outlook remains challenging with 57% analyst sell ratings and negative operating cash flow of $145M in 2025. While valuation metrics appear attractive with P/S of 0.65 and EV/EBITDA of 2.08, ongoing revenue declines and reliance on financing activities for liquidity pose significant risks. The turnaround strategy through product diversification faces execution challenges in a competitive plant-based protein market.

Cognizant Technology Solutions Corp

Cognizant (CTSH) trades at $44.16, up 3.74% today, with a bullish technical signal and strong support at $44. The stock shows solid fundamentals with a P/E of 9.58, revenue of $21.11B in 2025, and consistent earnings beats. Recent news highlights AI partnerships with Google Cloud and OpenAI, positioning the company for growth in enterprise AI services.

The outlook is positive with a consensus price target of $63.45, implying significant upside. Risks include competitive pressures and macroeconomic softness affecting demand. Analyst sentiment is mixed but leans bullish, with 43% buy ratings. The stock presents a value opportunity given its low valuation multiples and strategic AI investments.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Beyond Meat Inc

Beyond Meat is a provider of plant-based meats, such as burgers, sausage, ground beef, and chicken. Unlike other vegetarian products, Beyond Meat seeks to replicate the look, cook, and taste of meat, is targeted to omnivores and vegetarians alike, and is sold in the meat case. The products are widely available across the U.S. and Canada and in 83 additional countries as well. International revenue represented 31% of 2021 sales. The firm's products are available in retail stores and the food-service channel. In 2019, before the pandemic struck, sales were evenly split between these two channels, although mix stood at 70% retail/30% food service in 2021. We think the recovery from the crisis and new deals with McDonald's and Yum Brands will return food-service sales to nearly 50% in time.

Read more on BYND

About Cognizant Technology Solutions Corp

Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 300,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.

Read more on CTSH